Overview

Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea

Status:
Completed
Trial end date:
2017-11-27
Target enrollment:
Participant gender:
Summary
This study aims to validate a possible diagnostic test for bile acid diarrhoea prospectively compared to the SeHCAT scintigraphy. Fasting participants are given a standard meal and 1,250 mg chenodeoxycholic acid. The investigators measure fasting FGF19, bile acids species including 7-alpha-CHO and serial blood samples after the stimulation.
Phase:
Phase 4
Details
Lead Sponsor:
Lars Kristian Munck
Treatments:
Bile Acids and Salts
Chenodeoxycholic Acid